Drug Database
Back to search

Italy· 037109028

OLPREZIDE

A olmesartan medoxomil und diuretika product containing olmesartan medoxomil + idroclorotiazide, registered in Italy by MENARINI INTERNAT. O.L.S.A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC C09DA08

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedOLPREZIDEATCC09DA08REGISTER NO.037109028PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about olmesartan medoxomil + idroclorotiazideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil und diuretika is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DA08 (olmesartan medoxomil und diuretika), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 8 of them publish a price we can compare per daily dose
Search olmesartan medoxomil und diuretika products by name

Olmesartan medoxomil und diuretika · ATC C09DA08

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Olmesartan medoxomil + Idroclorotiazide
Manufacturer
MENARINI INTERNAT. O.L.S.A
Country
Italy (IT)
ATC code
C09DA08
ATC class
Olmesartan medoxomil und Diuretika
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    037109028
    "20 MG + 12,5 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PA/AL/PVC/AL
    EUR 7.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for olmesartan medoxomil und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check olmesartan medoxomil und diuretika against other medicinesHow interaction checks work

Olmesartan medoxomil und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DA08

Olmesartan medoxomil und diuretika, as other registers publish it.

All olmesartan medoxomil und diuretika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca26c738-cec5-4f41-8e18-84af3332944a
GET /v1/drugs/ca26c738-cec5-4f41-8e18-84af3332944a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"20 MG + 12,5 MG COMPRESSE RIVESTITE CON FILM\" 28 COMPRESSE IN BLISTER PA/AL/PVC/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Olmesartan medoxomil + Idroclorotiazide",
  "reference_pack": "28 UNITA' 20+12,5 MG - USO ORALE",
  "public_price_eur": 7.33,
  "ssn_reference_price_eur": 9.83
}
API referenceMCP serverPlans

See everything about olmesartan medoxomil und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console